{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T21:56:11Z","timestamp":1788472571378,"version":"build-2803163510"},"reference-count":33,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"DOI":"10.1001\/jamaoncol.2020.3187","type":"journal-article","created":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T11:32:01Z","timestamp":1598527921000},"page":"e203187","source":"Crossref","is-referenced-by-count":61,"title":["Tailoring Intensity of Active Surveillance for Low-Risk Prostate Cancer Based on Individualized Prediction of Risk Stability"],"prefix":"10.1001","volume":"6","author":[{"given":"Matthew R.","family":"Cooperberg","sequence":"first","affiliation":[{"name":"Helen Diller Family Comprehensive Cancer Center, Department of Urology, University of California, San Francisco"},{"name":"Department of Epidemiology & Biostatistics, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingye","family":"Zheng","sequence":"additional","affiliation":[{"name":"Fred Hutchinson Cancer Research Center, Biostatistics Program, Public Health Sciences, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna V.","family":"Faino","sequence":"additional","affiliation":[{"name":"Fred Hutchinson Cancer Research Center, Biostatistics Program, Public Health Sciences, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa F.","family":"Newcomb","sequence":"additional","affiliation":[{"name":"Fred Hutchinson Cancer Research Center, Cancer Prevention Program, Public Health Sciences, Seattle, Washington"},{"name":"Department of Urology, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kehao","family":"Zhu","sequence":"additional","affiliation":[{"name":"Fred Hutchinson Cancer Research Center, Biostatistics Program, Public Health Sciences, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet E.","family":"Cowan","sequence":"additional","affiliation":[{"name":"Helen Diller Family Comprehensive Cancer Center, Department of Urology, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Brooks","sequence":"additional","affiliation":[{"name":"Department of Urology, Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atreya","family":"Dash","sequence":"additional","affiliation":[{"name":"Department of Urology, Veterans Affairs Puget Sound Health Care System, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin E.","family":"Gleave","sequence":"additional","affiliation":[{"name":"Department of Urologic Sciences, University of British Columbia, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Martin","sequence":"additional","affiliation":[{"name":"Department of Urology, Eastern Virginia Medical School, Virginia Beach"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd M.","family":"Morgan","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S.","family":"Nelson","sequence":"additional","affiliation":[{"name":"Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian M.","family":"Thompson","sequence":"additional","affiliation":[{"name":"CHRISTUS Medical Center Hospital, San Antonio, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A.","family":"Wagner","sequence":"additional","affiliation":[{"name":"Division of Urology, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Carroll","sequence":"additional","affiliation":[{"name":"Helen Diller Family Comprehensive Cancer Center, Department of Urology, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel W.","family":"Lin","sequence":"additional","affiliation":[{"name":"Fred Hutchinson Cancer Research Center, Cancer Prevention Program, Public Health Sciences, Seattle, Washington"},{"name":"Department of Urology, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2020,10,8]]},"reference":[{"issue":"1","key":"coi200056r1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.v70.1","article-title":"Cancer statistics, 2020.","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"coi200056r2","author":"Ganz","year":"2012","journal-title":"Ann Intern Med"},{"issue":"1","key":"coi200056r3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1001\/jama.2015.6036","article-title":"Trends in management for patients with localized prostate cancer, 1990-2013.","volume":"314","author":"Cooperberg","year":"2015","journal-title":"JAMA"},{"issue":"10","key":"coi200056r4","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1001\/jamasurg.2017.1586","article-title":"Practice- vs physician-level variation in use of active surveillance for men with low-risk prostate cancer: implications for collaborative quality improvement.","volume":"152","author":"Auffenberg","year":"2017","journal-title":"JAMA Surg"},{"issue":"18","key":"coi200056r5","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1200\/JCO.2015.65.7759","article-title":"Active surveillance for the management of localized prostate cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology clinical practice guideline endorsement.","volume":"34","author":"Chen","year":"2016","journal-title":"J Clin Oncol"},{"issue":"3","key":"coi200056r6","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.juro.2017.11.095","article-title":"Clinically localized prostate cancer: AUA\/ASTRO\/SUO guideline. Part I: risk stratification, shared decision making, and care options.","volume":"199","author":"Sanda","year":"2018","journal-title":"J Urol"},{"issue":"2","key":"coi200056r7","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ucl.2014.01.011","article-title":"Optimization of prostate biopsy: review of technique and complications.","volume":"41","author":"Bjurlin","year":"2014","journal-title":"Urol Clin North Am"},{"issue":"4","key":"coi200056r8","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.eururo.2018.05.014","article-title":"The diverse genomic landscape of clinically low-risk prostate cancer.","volume":"74","author":"Cooperberg","year":"2018","journal-title":"Eur Urol"},{"issue":"2","key":"coi200056r9","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.juro.2015.08.087","article-title":"Outcomes of active surveillance for clinically localized prostate cancer in the prospective, multi-institutional Canary PASS cohort.","volume":"195","author":"Newcomb","year":"2016","journal-title":"J Urol"},{"issue":"5","key":"coi200056r11","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.euo.2018.04.018","article-title":"Effects of initial Gleason grade on outcomes during active surveillance for prostate cancer.","volume":"1","author":"Masic","year":"2018","journal-title":"Eur Urol Oncol"},{"issue":"2","key":"coi200056r12","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.eururo.2018.01.017","article-title":"Refined analysis of prostate-specific antigen kinetics to predict prostate cancer active surveillance outcomes.","volume":"74","author":"Cooperberg","year":"2018","journal-title":"Eur Urol"},{"issue":"2","key":"coi200056r13","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/biom.2005.61.issue-2","article-title":"Partly conditional survival models for longitudinal data.","volume":"61","author":"Zheng","year":"2005","journal-title":"Biometrics"},{"key":"coi200056r14","doi-asserted-by":"crossref","DOI":"10.1111\/biom.12562","article-title":"On longitudinal prediction with time-to-event outcome: comparison of modeling options.","author":"Maziarz","year":"2017","journal-title":"Biometrics"},{"key":"coi200056r15","doi-asserted-by":"crossref","DOI":"10.7326\/M17-0548","article-title":"Comparative analysis of biopsy upgrading in four prostate cancer active surveillance cohorts.","author":"Inoue","year":"2018","journal-title":"Ann Intern Med"},{"issue":"1","key":"coi200056r16","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/biom.2005.61.issue-1","article-title":"Survival model predictive accuracy and ROC curves.","volume":"61","author":"Heagerty","year":"2005","journal-title":"Biometrics"},{"issue":"4","key":"coi200056r19","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.eururo.2016.08.003","article-title":"EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent.","volume":"71","author":"Mottet","year":"2017","journal-title":"Eur Urol"},{"issue":"12","key":"coi200056r20","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1093\/jnci\/djp122","article-title":"Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis.","volume":"101","author":"Cooperberg","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"coi200056r21","doi-asserted-by":"crossref","DOI":"10.1111\/bju.12554","article-title":"Limited ability of existing nomograms to predict outcomes in men undergoing active surveillance for prostate cancer.","author":"Wang","year":"2014","journal-title":"BJU Int"},{"issue":"3 pt 1","key":"coi200056r22","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.juro.2016.09.071","article-title":"Variation in guideline concordant active surveillance followup in diverse urology practices.","volume":"197","author":"Luckenbaugh","year":"2017","journal-title":"J Urol"},{"key":"coi200056r23","author":"Hamdy","journal-title":"N Engl J Med"},{"key":"coi200056r24","doi-asserted-by":"crossref","DOI":"10.1016\/j.euf.2017.11.010","article-title":"Prostate magnetic resonance imaging interpretation varies substantially across radiologists.","author":"Sonn","year":"2019","journal-title":"Eur Urol Focus"},{"issue":"2","key":"coi200056r25","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/jmri.v45.2","article-title":"Accuracy and agreement of PIRADSv2 for prostate cancer mpMRI: a multireader study.","volume":"45","author":"Greer","year":"2017","journal-title":"J Magn Reson Imaging"},{"issue":"21","key":"coi200056r26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1172\/jci.insight.123468","article-title":"Transcriptomic heterogeneity in multifocal prostate cancer.","volume":"3","author":"Salami","year":"2018","journal-title":"JCI Insight"},{"issue":"36","key":"coi200056r27","doi-asserted-by":"publisher","first-page":"9067","DOI":"10.1200\/JCO.2004.01.0454","article-title":"Reporting recommendations for tumor marker prognostic studies.","volume":"23","author":"McShane","year":"2005","journal-title":"J Clin Oncol"},{"issue":"24","key":"coi200056r28","doi-asserted-by":"publisher","first-page":"6046","DOI":"10.1002\/cncr.27670","article-title":"The quantitative Gleason score improves prostate cancer risk assessment.","volume":"118","author":"Reese","year":"2012","journal-title":"Cancer"},{"issue":"4","key":"coi200056r29","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.eururo.2015.10.029","article-title":"Clinical utility of quantitative Gleason grading in prostate biopsies and prostatectomy specimens.","volume":"69","author":"Sauter","year":"2016","journal-title":"Eur Urol"},{"issue":"2","key":"coi200056r30","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.juro.2011.03.115","article-title":"The potential impact of reproducibility of Gleason grading in men with early stage prostate cancer managed by active surveillance: a multi-institutional study.","volume":"186","author":"McKenney","year":"2011","journal-title":"J Urol"},{"issue":"3","key":"coi200056r31","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.eururo.2016.04.021","article-title":"Quantified clinical risk change as an end point during prostate cancer active surveillance.","volume":"72","author":"Leapman","year":"2017","journal-title":"Eur Urol"},{"issue":"18","key":"coi200056r32","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2018.3710","article-title":"Screening for prostate cancer: US Preventive Services Task Force recommendation statement.","volume":"319","author":"Grossman","year":"2018","journal-title":"JAMA"},{"key":"coi200056r33","author":"Keegan","year":"2012","journal-title":"Cancer"},{"key":"coi200056r10","unstructured":"Prostate Active Surveillance Study (PASS). Clinicaltrials.gov identifier: NCT00756665. Updated December 23, 2019. Accessed July 22, 2020. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00756665?term=NCT00756665&draw=2&rank=1"},{"key":"coi200056r17","unstructured":"RStudio. shinyapps.io. Accessed July 28, 2020. https:\/\/www.shinyapps.io\/"},{"key":"coi200056r18","unstructured":"Prostate Active Surveillance Study. Canary PASS active surveillance risk calculators. Accessed July 28, 2020. https:\/\/canarypass.org\/calculators\/"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2769893\/jamaoncology_cooperberg_2020_oi_200056_1619718174.39689.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T14:31:02Z","timestamp":1619706662000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2769893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,8]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2020.3187","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.738564674.793581325","asserted-by":"object"}]},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,8]]}}}